Key Surgical Locks In Merger With German Sterile Processing Firm

 
• By Catherine Longworth

US sterile processing supplies firm Key Surgical has merged with European rival Interlock to create a global organization. The deal follows on Interlock’s acquisition last year of UK company Clinipak. Financial terms of the deal were not disclosed.

US company Key Surgical has merged with its German rival, Interlock, to form a global sterile processing organization. The deal follows on from Interlock's acquisition last year of UK company Clinipak. Healthcare investor, Water Street Healthcare Partners, led the merger of the businesses. Financial terms of the deal were not disclosed.

Key Surgical president and chief operating officer Brian O'Connell told Medtech Insight the merger positions the company as a global...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By Elizabeth Orr

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.

Philips Deals Itself A Strong Hand In POCUS Stakes

 
• By Ashley Yeo

Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 
• By Natasha Barrow

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.